0001144204-19-001103.txt : 20190108 0001144204-19-001103.hdr.sgml : 20190108 20190108163855 ACCESSION NUMBER: 0001144204-19-001103 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190102 FILED AS OF DATE: 20190108 DATE AS OF CHANGE: 20190108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: THANGARAJ IMMANUEL CENTRAL INDEX KEY: 0001213308 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10113 FILM NUMBER: 19516366 MAIL ADDRESS: STREET 1: 10001 WOODLOCH FOREST DRIVE SUITE 175 CITY: THE WOODLANDS STATE: TX ZIP: 77380 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACURA PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0000786947 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 110853640 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 616 N. NORTH COURT, SUITE 120 CITY: PALATINE STATE: IL ZIP: 60067 BUSINESS PHONE: 847-705-7709 MAIL ADDRESS: STREET 1: 616 N. NORTH COURT, SUITE 120 STREET 2: . CITY: PALATINE STATE: IL ZIP: 60067 FORMER COMPANY: FORMER CONFORMED NAME: HALSEY DRUG CO INC/NEW DATE OF NAME CHANGE: 19920703 4 1 tv510618_4.xml OWNERSHIP DOCUMENT X0306 4 2019-01-02 0 0000786947 ACURA PHARMACEUTICALS, INC ACUR 0001213308 THANGARAJ IMMANUEL 10001 WOODLOCH FOREST DRIVE SUITE 175 THE WOODLANDS TX 77380 1 0 0 0 Common Stock 2019-01-02 4 M 0 66666 A 126192 D Common Stock 1956396 I By Essex Woodlands Health Venture Fund V, L.P. Restricted Stock Units (2017 Plan) 2019-01-02 4 M 0 66666 D Common Stock 66666 0 D Restricted Stock Units (2017 Plan) 2019-01-02 4 A 0 83333 A Common Stock 83333 83333 D Represents exchange of restricted stock units. Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock Does not include Restricted Stock Units. 1 - for - 1 25% of Restricted Stock Units vested on March 31, 2018, 25% vested on June 30, 2018; 25% vested on September 30, 2018 and 25% vested on December 31, 2018. Restricted Stock Units are being exchanged on a one for one basis for common stock, in each case upon payment of par value. N/A 25% of Restricted Stock Units vest on the last day of each of March, June, September and December 2019, subject to immediate vesting in the event of a change of control and certain other events. Reporting Person may elect to exchange up to 40% of Restricted Stock Units for cash and the remaining Restricted Stock Units will be exchanged on a one for one basis for common stock, in each case upon payment of, or deduction of par value. Distributions in respect of vested Restricted Stock Units will be made on the first business day of January 2020, or earlier upon a change of control. The reporting person is a managing director of the general partner of Essex Woodlands Health Ventures Fund V, L.P. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. /s/ Bruce Wesson 2019-01-08